June 2007: Candytuft and Dyspepsia
Because dyspepsia has, by definition, no known medical cause, there is no apparent way to develop medical treatments to address it. Many people with dyspepsia simply experiment with medications, as well as remove foods from their diet. However, substantial
A double-blind study published in May 2007 enrolled a total of 315 people with dyspepsia. Researchers evaluated the severity of the condition through the use of a standardized questionnaire, the Gastrointestinal Symptom Score (GIS) scale. Participants received either placebo or Iberogast at a dose of 20 drops three times daily. Over the eight-week study period, participants given Iberogast showed significantly greater improvement in GIS scores than those given placebo.
Several earlier double-blind studies, enrolling a total of about 300 people, had also shown benefit. However, many of these used an earlier version of Iberogast that lacked some of the herbs used in the current product.
von Arnim U, Peitz U, Vinson B, et al. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol . 2007;102:1268-75.
Last reviewed by
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2007 EBSCO Publishing All rights reserved.